We have compared cytoplasmic extracts from chicken DU249 cells at various stages along the apoptotic pathway. Extracts from morphologically normal “committed stage” cells induce apoptotic morphology and DNA cleavage in substrate nuclei but require ongoing caspase activity to do so. In contrast, extracts from frankly apoptotic cells induce apoptotic events in added nuclei in a caspase-independent manner. Biochemical fractionation of these extracts reveals that a column fraction enriched in endogenous active caspases is unable to induce DNA fragmentation or chromatin condensation in substrate nuclei, whereas a caspase-depleted fraction induces both changes. Further characterization of the “execution phase” extracts revealed the presence of an ICAD/DFF45 (inhibitor of caspase-activated DNase/DNA fragmentation factor)- inhibitable nuclease resembling CAD, plus another activity that was required for the apoptotic chromatin condensation. Despite the presence of active caspases, committed stage extracts lacked these downstream activities, suggesting that the caspases and downstream factors are segregated from one another in vivo during the latent phase. These observations not only indicate that caspases act in an executive fashion, serving to activate downstream factors that disassemble the nucleus rather than disassembling it themselves, but they also suggest that activation of the downstream factors (rather than the caspases) is the critical event that occurs at the transition from the latent to active phase of apoptosis.
Skip Nav Destination
Article navigation
5 October 1998
Article|
October 05 1998
Transition from Caspase-dependent to Caspase-independent Mechanisms at the Onset of Apoptotic Execution
Kumiko Samejima,
Kumiko Samejima
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Shigenobu Toné,
Shigenobu Toné
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Timothy J. Kottke,
Timothy J. Kottke
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Masato Enari,
Masato Enari
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Hideki Sakahira,
Hideki Sakahira
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Carol A. Cooke,
Carol A. Cooke
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Françoise Durrieu,
Françoise Durrieu
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Luis M. Martins,
Luis M. Martins
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Shigekazu Nagata,
Shigekazu Nagata
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Scott H. Kaufmann,
Scott H. Kaufmann
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
William C. Earnshaw
William C. Earnshaw
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
Search for other works by this author on:
Kumiko Samejima
,
Shigenobu Toné
,
Timothy J. Kottke
,
Masato Enari
,
Hideki Sakahira
,
Carol A. Cooke
,
Françoise Durrieu
,
Luis M. Martins
,
Shigekazu Nagata
,
Scott H. Kaufmann
,
William C. Earnshaw
*Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Edinburgh, EH9 3JR, Scotland, United Kingdom; ‡Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905; and §Department of Genetics, Osaka University Medical School, Suita, Osaka 565, Japan
K. Samejima and S. Toné contributed equally to this work.
Correspondence should be addressed to W.C. Earnshaw, Institute of Cell and Molecular Biology, University of Edinburgh, Kings' Buildings, Mayfield Road, Edinburgh, EH9 3JR, Scotland, UK. Tel.: 44-(0)131-650-7101. Fax: 44-(0)131-650-7100. E-mail: [email protected]
Received:
July 20 1998
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1998
J Cell Biol (1998) 143 (1): 225–239.
Article history
Received:
July 20 1998
Citation
Kumiko Samejima, Shigenobu Toné, Timothy J. Kottke, Masato Enari, Hideki Sakahira, Carol A. Cooke, Françoise Durrieu, Luis M. Martins, Shigekazu Nagata, Scott H. Kaufmann, William C. Earnshaw; Transition from Caspase-dependent to Caspase-independent Mechanisms at the Onset of Apoptotic Execution . J Cell Biol 5 October 1998; 143 (1): 225–239. doi: https://doi.org/10.1083/jcb.143.1.225
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
